Bartter's syndrome and chondrocalcinosis: A possible role for hypomagnesemia in the deposition of calcium pyrophosphate dihydrate (CPPD) crystals

C. Salvarani, F. Rossi, P. L. Macchioni, R. Baricchi, N. Capozzoli, S. Castellani, L. Ghirelli, M. Veneziani, L. Scarti, I. Portioli

Research output: Contribution to journalArticle

Abstract

A new case of association between Bartter's syndrome and chondrocalcinosis is reported. The patient was shown to have marked hypomagnesium. Indomethacin and magnesium therapy was started and resulted in increased magnesemia, even if it did not reach normal levels. There was complete remission of articular symptoms and no progression on the radiological picture after 2 years of continuous magnesium and indomethacin therapy. The 7 available family members were studied to assess the possible presence of a familial form of chondrocalcinosis and/or hypomagnesemia. The literature is reviewed and reports of previously described associations between Bartter's syndrome and chondrocalcinosis are summarized. The possible role of hypomagnesemia in predisposing to deposition of calcium pyrophosphate dihydrate crystal in cartilagine is also discussed.

Original languageEnglish
Pages (from-to)415-420
Number of pages6
JournalClinical and Experimental Rheumatology
Volume7
Issue number4
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Fingerprint Dive into the research topics of 'Bartter's syndrome and chondrocalcinosis: A possible role for hypomagnesemia in the deposition of calcium pyrophosphate dihydrate (CPPD) crystals'. Together they form a unique fingerprint.

  • Cite this

    Salvarani, C., Rossi, F., Macchioni, P. L., Baricchi, R., Capozzoli, N., Castellani, S., Ghirelli, L., Veneziani, M., Scarti, L., & Portioli, I. (1989). Bartter's syndrome and chondrocalcinosis: A possible role for hypomagnesemia in the deposition of calcium pyrophosphate dihydrate (CPPD) crystals. Clinical and Experimental Rheumatology, 7(4), 415-420.